Interim Report: No Diovan Data Falsification Detected In Nagoya Heart Study
This article was originally published in PharmAsia News
Executive Summary
No immediate traces of data manipulation were discovered in the Nagoya Heart Study involving the antihypertensive drug Diovan (valsartan), according to an interim report released by Nagoya University`s School of Medicine.